AZN logo

AstraZeneca PLC (AZN) Cash from investing

annual CFI:

-$7.98B-$3.92B(-96.36%)
December 31, 2024

Summary

  • As of today (August 21, 2025), AZN annual cash flow from investing activities is -$7.98 billion, with the most recent change of -$3.92 billion (-96.36%) on December 31, 2024.
  • During the last 3 years, AZN annual CFI has risen by +$3.08 billion (+27.84%).
  • AZN annual CFI is now -922.68% below its all-time high of $970.00 million, reached on December 31, 2004.

Performance

AZN Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

quarterly CFI:

-$2.20B-$881.01M(-66.74%)
June 30, 2025

Summary

  • As of today (August 21, 2025), AZN quarterly cash flow from investing activities is -$2.20 billion, with the most recent change of -$881.01 million (-66.74%) on June 30, 2025.
  • Over the past year, AZN quarterly CFI has increased by +$783.99 million (+26.26%).
  • AZN quarterly CFI is now -222.47% below its all-time high of $1.80 billion, reached on June 30, 2006.

Performance

AZN quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

TTM CFI:

-$6.35B+$783.99M(+10.98%)
June 30, 2025

Summary

  • As of today (August 21, 2025), AZN TTM cash flow from investing activities is -$6.35 billion, with the most recent change of +$783.99 million (+10.98%) on June 30, 2025.
  • Over the past year, AZN TTM CFI has increased by +$1.59 billion (+20.01%).
  • AZN TTM CFI is now -525.05% below its all-time high of $1.49 billion, reached on June 30, 2005.

Performance

AZN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AZN Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-96.4%+26.3%+20.0%
3 y3 years+27.8%-172.7%+49.2%
5 y5 years-1114.6%-1683.5%-3276.5%

AZN Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-169.6%+27.8%-677.7%+26.3%-110.4%+49.2%
5 y5-year-2700.0%+27.8%-514.5%+79.0%-3014.2%+49.2%
alltimeall time-922.7%+46.4%-222.5%+84.3%-525.0%+63.7%

AZN Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$2.20B(+66.7%)
-$6.35B(-11.0%)
Mar 2025
-
-$1.32B(+6.2%)
-$7.14B(-14.2%)
Dec 2024
-$7.98B(+96.4%)
-$1.24B(-21.8%)
-$8.32B(+1.1%)
Sep 2024
-
-$1.59B(-46.8%)
-$8.24B(+3.7%)
Jun 2024
-
-$2.98B(+19.1%)
-$7.94B(+43.3%)
Mar 2024
-
-$2.51B(+116.8%)
-$5.54B(+27.4%)
Dec 2023
-$4.06B(+37.3%)
-$1.16B(-10.7%)
-$4.35B(+25.1%)
Sep 2023
-
-$1.29B(+120.6%)
-$3.48B(-11.8%)
Jun 2023
-
-$587.00M(-55.3%)
-$3.94B(-5.3%)
Mar 2023
-
-$1.31B(+364.0%)
-$4.16B(+37.8%)
Dec 2022
-$2.96B(-73.2%)
-$283.00M(-83.9%)
-$3.02B(-20.6%)
Sep 2022
-
-$1.76B(+118.0%)
-$3.81B(-69.6%)
Jun 2022
-
-$807.00M(+371.9%)
-$12.51B(+4.8%)
Mar 2022
-
-$171.00M(-84.0%)
-$11.94B(+6.2%)
Dec 2021
-$11.06B(+3780.0%)
-$1.07B(-89.8%)
-$11.24B(+12.0%)
Sep 2021
-
-$10.46B(+4278.7%)
-$10.04B(+6174.4%)
Jun 2021
-
-$239.00M(-145.0%)
-$160.00M(-173.4%)
Mar 2021
-
$531.00M(+296.3%)
$218.00M(-165.7%)
Dec 2020
-$285.00M(-56.6%)
$134.00M(-122.9%)
-$332.00M(-21.9%)
Sep 2020
-
-$586.00M(-521.6%)
-$425.00M(-312.5%)
Jun 2020
-
$139.00M(-831.6%)
$200.00M(-118.3%)
Mar 2020
-
-$19.00M(-146.3%)
-$1.09B(+39.8%)
Dec 2019
-$657.00M(-168.2%)
$41.00M(+5.1%)
-$781.00M(-1339.7%)
Sep 2019
-
$39.00M(-103.4%)
$63.00M(-142.9%)
Jun 2019
-
-$1.15B(-494.9%)
-$147.00M(-117.9%)
Mar 2019
-
$292.00M(-67.0%)
$822.00M(+6.8%)
Dec 2018
$963.00M(-141.4%)
$885.00M(-617.5%)
$770.00M(-142.7%)
Sep 2018
-
-$171.00M(-7.1%)
-$1.80B(-10.3%)
Jun 2018
-
-$184.00M(-176.7%)
-$2.01B(-2.5%)
Mar 2018
-
$240.00M(-114.2%)
-$2.06B(-17.3%)
Dec 2017
-$2.33B(-41.3%)
-$1.69B(+346.6%)
-$2.49B(+955.9%)
Sep 2017
-
-$378.00M(+60.9%)
-$236.00M(-55.0%)
Jun 2017
-
-$235.00M(+23.0%)
-$524.00M(-61.8%)
Mar 2017
-
-$191.00M(-133.6%)
-$1.37B(-66.6%)
Dec 2016
-$3.97B(-6.4%)
$568.00M(-185.3%)
-$4.11B(-43.6%)
Sep 2016
-
-$666.00M(-38.4%)
-$7.28B(+2.9%)
Jun 2016
-
-$1.08B(-63.1%)
-$7.08B(+5.8%)
Mar 2016
-
-$2.93B(+12.4%)
-$6.70B(+53.5%)
Dec 2015
-$4.24B(-39.7%)
-$2.61B(+462.9%)
-$4.36B(+31.2%)
Sep 2015
-
-$463.00M(-33.6%)
-$3.32B(-3.7%)
Jun 2015
-
-$697.00M(+16.9%)
-$3.45B(-12.9%)
Mar 2015
-
-$596.00M(-62.0%)
-$3.96B(-44.8%)
Dec 2014
-$7.03B(+143.4%)
-$1.57B(+165.3%)
-$7.17B(+8.1%)
Sep 2014
-
-$591.00M(-51.0%)
-$6.64B(-1.3%)
Jun 2014
-
-$1.21B(-68.3%)
-$6.73B(+4.9%)
Mar 2014
-
-$3.81B(+268.6%)
-$6.41B(+114.6%)
Dec 2013
-$2.89B(+55.4%)
-$1.03B(+51.7%)
-$2.99B(+18.7%)
Sep 2013
-
-$680.78M(-23.7%)
-$2.52B(-44.8%)
Jun 2013
-
-$892.47M(+133.4%)
-$4.56B(+55.3%)
Mar 2013
-
-$382.43M(-32.0%)
-$2.93B(+45.9%)
Dec 2012
-$1.86B(-8.1%)
-$562.21M(-79.3%)
-$2.01B(-60.3%)
Sep 2012
-
-$2.72B(-472.0%)
-$5.07B(+351.7%)
Jun 2012
-
$731.31M(+35.3%)
-$1.12B(-34.2%)
Mar 2012
-
$540.32M(-114.9%)
-$1.71B(-22.1%)
Dec 2011
-$2.02B
-$3.62B(-395.0%)
-$2.19B(-341.8%)
Sep 2011
-
$1.23B(+725.9%)
$905.59M(-826.9%)
DateAnnualQuarterlyTTM
Jun 2011
-
$148.63M(+166.8%)
-$124.58M(-89.6%)
Mar 2011
-
$55.71M(-110.6%)
-$1.19B(-52.5%)
Dec 2010
-$2.23B(-10.1%)
-$526.29M(-366.6%)
-$2.52B(-35.7%)
Sep 2010
-
$197.37M(-121.4%)
-$3.91B(-14.3%)
Jun 2010
-
-$921.71M(-27.2%)
-$4.57B(+17.4%)
Mar 2010
-
-$1.27B(-34.1%)
-$3.89B(+51.2%)
Dec 2009
-$2.48B(-36.4%)
-$1.92B(+322.0%)
-$2.57B(+113.3%)
Sep 2009
-
-$455.55M(+85.7%)
-$1.21B(+20.1%)
Jun 2009
-
-$245.37M(-591.5%)
-$1.00B(-3.8%)
Mar 2009
-
$49.92M(-109.0%)
-$1.04B(-74.4%)
Dec 2008
-$3.90B(-73.8%)
-$555.42M(+119.3%)
-$4.08B(+1.4%)
Sep 2008
-
-$253.31M(-11.1%)
-$4.02B(+5.6%)
Jun 2008
-
-$284.90M(-90.5%)
-$3.81B(-78.2%)
Mar 2008
-
-$2.99B(+498.5%)
-$17.50B(+14.8%)
Dec 2007
-$14.89B(+5373.2%)
-$499.00M(+1117.1%)
-$15.24B(+4.7%)
Sep 2007
-
-$41.00M(-99.7%)
-$14.55B(-4.0%)
Jun 2007
-
-$13.98B(+1817.1%)
-$15.17B(-2594.2%)
Mar 2007
-
-$729.00M(-479.7%)
$608.03M(-197.4%)
Dec 2006
-$272.00M(-77.0%)
$192.00M(-129.4%)
-$624.00M(-56.9%)
Sep 2006
-
-$652.22M(-136.3%)
-$1.45B(-28.8%)
Jun 2006
-
$1.80B(-191.6%)
-$2.03B(-38.8%)
Mar 2006
-
-$1.96B(+211.1%)
-$3.32B(+139.2%)
Dec 2005
-$1.18B(-221.9%)
-$630.35M(-49.1%)
-$1.39B(-257.2%)
Sep 2005
-
-$1.24B(-342.8%)
$883.22M(-40.9%)
Jun 2005
-
$509.67M(-1822.4%)
$1.49B(+4.7%)
Mar 2005
-
-$29.59M(-101.8%)
$1.43B(+69.0%)
Dec 2004
$970.00M(-213.8%)
$1.64B(-362.0%)
$845.00M(-160.8%)
Sep 2004
-
-$626.31M(-241.3%)
-$1.39B(+27.9%)
Jun 2004
-
$443.23M(-172.3%)
-$1.09B(-39.3%)
Mar 2004
-
-$612.79M(+3.2%)
-$1.79B(+18.0%)
Dec 2003
-$852.00M(-44.8%)
-$593.97M(+83.8%)
-$1.52B(+5.9%)
Sep 2003
-
-$323.21M(+24.5%)
-$1.43B(-5.2%)
Jun 2003
-
-$259.68M(-23.7%)
-$1.51B(-5.4%)
Mar 2003
-
-$340.13M(-33.3%)
-$1.60B(+3.6%)
Dec 2002
-$1.54B(-2.8%)
-$509.94M(+26.8%)
-$1.54B(-2.8%)
Sep 2002
-
-$402.17M(+16.3%)
-$1.59B(-1.1%)
Jun 2002
-
-$345.89M(+21.4%)
-$1.60B(+6.2%)
Mar 2002
-
-$285.00M(-48.6%)
-$1.51B(-4.8%)
Dec 2001
-$1.59B(+22.7%)
-$554.28M(+32.2%)
-$1.59B(+19.6%)
Sep 2001
-
-$419.33M(+66.2%)
-$1.33B(-31.4%)
Jun 2001
-
-$252.28M(-30.1%)
-$1.93B(+42.3%)
Mar 2001
-
-$361.11M(+22.7%)
-$1.36B(+5.1%)
Dec 2000
-$1.29B(+71.8%)
-$294.29M(-71.3%)
-$1.29B(+29.5%)
Sep 2000
-
-$1.03B(-418.4%)
-$999.17M(-3668.0%)
Jun 2000
-
$322.62M(-209.5%)
$28.00M(-109.5%)
Mar 2000
-
-$294.62M
-$294.62M
Dec 1999
-$753.00M(-77.7%)
-
-
Dec 1998
-$3.38B(+489.6%)
-
-
Dec 1997
-$573.63M(+4.7%)
-
-
Dec 1996
-$548.00M(-15.6%)
-
-
Dec 1995
-$648.99M(+44.1%)
-
-
Dec 1994
-$450.26M(+15.7%)
-
-
Dec 1993
-$389.03M(+45.7%)
-
-
Dec 1992
-$266.94M(+30.9%)
-
-
Dec 1991
-$203.96M(+211.0%)
-
-
Dec 1990
-$65.58M
-
-

FAQ

  • What is AstraZeneca PLC annual cash flow from investing activities?
  • What is the all time high annual CFI for AstraZeneca PLC?
  • What is AstraZeneca PLC annual CFI year-on-year change?
  • What is AstraZeneca PLC quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for AstraZeneca PLC?
  • What is AstraZeneca PLC quarterly CFI year-on-year change?
  • What is AstraZeneca PLC TTM cash flow from investing activities?
  • What is the all time high TTM CFI for AstraZeneca PLC?
  • What is AstraZeneca PLC TTM CFI year-on-year change?

What is AstraZeneca PLC annual cash flow from investing activities?

The current annual CFI of AZN is -$7.98B

What is the all time high annual CFI for AstraZeneca PLC?

AstraZeneca PLC all-time high annual cash flow from investing activities is $970.00M

What is AstraZeneca PLC annual CFI year-on-year change?

Over the past year, AZN annual cash flow from investing activities has changed by -$3.92B (-96.36%)

What is AstraZeneca PLC quarterly cash flow from investing activities?

The current quarterly CFI of AZN is -$2.20B

What is the all time high quarterly CFI for AstraZeneca PLC?

AstraZeneca PLC all-time high quarterly cash flow from investing activities is $1.80B

What is AstraZeneca PLC quarterly CFI year-on-year change?

Over the past year, AZN quarterly cash flow from investing activities has changed by +$783.99M (+26.26%)

What is AstraZeneca PLC TTM cash flow from investing activities?

The current TTM CFI of AZN is -$6.35B

What is the all time high TTM CFI for AstraZeneca PLC?

AstraZeneca PLC all-time high TTM cash flow from investing activities is $1.49B

What is AstraZeneca PLC TTM CFI year-on-year change?

Over the past year, AZN TTM cash flow from investing activities has changed by +$1.59B (+20.01%)
On this page